News
Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)
Lonza to Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)
COLTENE announces 2022 half-year results and outlook
COLTENE announces 2022 half-year results and outlook
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001
Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Annual General Shareholders’ Meeting 2022: Sonova shareholders approve all motions of the Board of Directors
Annual General Shareholders’ Meeting 2022:
Sonova shareholders approve all motions of the Board of Directors
Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil
Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil
Annual General Meeting of Kuros Biosciences approves all resolutions
Annual General Meeting of Kuros Biosciences approves all resolutions
Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001
Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment
Relief Therapeutics Announces Results of Annual General Meeting of RELIEF THERAPEUTICS Holding SA
Relief Therapeutics Announces Results of Annual General Meeting of RELIEF THERAPEUTICS Holding SA
Relief Provides a Corporate Update and Comments on the Recently Announced DSMB Update on the U.S. National Institutes of Health (NIH) Study of Intravenous Aviptadil in Critical COVID-19 Patients
Relief Provides a Corporate Update and Comments on the Recently Announced DSMB Update on the U.S. National Institutes of Health (NIH) Study of Intravenous Aviptadil in Critical COVID-19 Patients
Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial
Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial
Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Board (DSMB) Update on the U.S. National Institutes of Health (NIH) Study of aviptadil in Critical COVID-19
Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Board (DSMB) Update on the U.S. National Institutes of Health (NIH) Study of aviptadil in Critical COVID-19
DGAP-News: BB BIOTECH AG: Disruptive technologies are changing an entire industry
DGAP-News: BB BIOTECH AG: Disruptive technologies are changing an entire industry
Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
Straumann Group to acquire PlusDental, a doctor-led clear-aligner treatment solutions provider in Europe
Straumann Group to acquire PlusDental, a doctor-led clear-aligner treatment solutions provider in Europe
Evolva business update: On track to reach 2022 guidance
Evolva business update: On track to reach 2022 guidance
Kuros Biosciences announces commercial launch of MagnetOs Easypack Putty in the U.S.
Kuros Biosciences announces commercial launch of
MagnetOs Easypack Putty in the U.S.
Financial year 2021/22: Sonova delivers solid results and significantly advances its growth strategy
Financial year 2021/22: Sonova delivers solid results
and significantly advances its growth strategy
Update on the timeline for Vifor Pharma tender offer
Regulatory News:
CSL Limited (ASX: CSL; USOTC:CSLLY) yesterday announced an update regarding the Vifor Pharma AG acquisition. CSL has previously advised that it expected to be in a position to
Update zum Zeitplan des öffentlichen Kaufangebots für Vifor Pharma
Regulatory News:
CSL Limited (ASX: CSL; USOTC:CSLLY) hat gestern ein Update bezüglich der Übernahme der Vifor Pharma AG veröffentlicht. CSL hat zuvor mitgeteilt, dass das Unternehmen die
Evolva signs distribution agreement for its Veri-teTM Resveratrol for dietary supplements in Brazil
Evolva signs distribution agreement for its Veri-teTM Resveratrol for dietary supplements in Brazil
Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Relief Therapeutics to Participate in Industry and Investor Conferences in May
Relief Therapeutics to Participate in Industry and Investor Conferences in May